The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

The U.S. Food and Drug Administration has approved GSK's add-on drug to treat asthma and a chronic inflammatory sinus condition, the drugmaker said on Tuesday, paving the way for a less frequently ...

UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma in patients aged ...

How scented candles and fires could affect your lungs this holiday season - Airborne particles can potentially trigger ...

While humidifiers provide real relief, many people aren’t entirely sure how they work or how to use them safely. Here’s what to know.

Vermont Business Magazine New research from the University of Vermont reveals exposure to smoke from Canadian wildfires in ...

Looking at hospital-level specific services, the greatest declines were for moderate-intensity services including ...

Asthma flareups can be frightening, but families in King County don’t have to face them alone. For more than 20 years, the King County Community Health Worker (CHW) Asthma Program at Public Health – ...

“You can do absolutely anything you want with asthma,” says Van Dyken, who had won six Olympic gold medals by the time she ...

As it rolls out its US Technegas platform for detecting pulmonary embolisms, Cyclopharm is eyeing other indications including ...

A state investigation cited two violations against the Proctor facility involving maltreatment of a vulnerable adult.

Abstract: Gait abnormalities are common in the older population owing to aging- and disease-related changes in physical and neurological functions. Differentiating the causes of gait abnormalities is ...